Stage III Grade 3 Follicular Lymphoma Active Not Recruiting Phase Trials for Bortezomib (DB00188)

IndicationStatusPhase
DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma)Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02037256Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell TransplantTreatment